Event: PharmAsia Conference
Speakers:
Meet the Most Senior Level Speakers in the Business, including:
Frank Jiang
VP Global R&D Head, China R&D Head
Sanofi-Aventis
Tony Zhang
Managing Director and Site Head
Eli Lilly Global R&D, China
Samantha Du
CEO
Hutchison Pharma
Ge Li
CEO
WuXi Apptec
Ding Ding
Senior Equity Analyst
China Health Care, Susquehanna
Andrew von Eschenbach
Former FDA Commissioner
Alex Wu
CEO
Crown Bio
G.V. Prasad
Vice Chairman and CEO
Dr. Reddy’s Laboratories
Kiran Marthak
CEO
Veeda
Robert Armstrong
VP, Global External Research and Development
Eli Lilly and Company
Jonathon Wang
Senior Managing Director, Asia
OrbiMed Advisors
Zhu Shen
CEO
BioForesight
Yael Weiss, MD, PhD
Director, Licensing And External Research Merck Research Laboratories
Li Chen
Chief Scientific Officer
Roche R&D Center (China) Ltd.
Song Ruilin
Executive Director-General Research Center for Medicinal Policy
Chinese Pharmaceutical Association
Dates: Oct. 26-28, 2009
Location: Intercontinental Mark Hopkins • San Francisco
Cost: $1,795,including two nights at the Intercontinental Mark Hopkins
See detailed agenda at http://www.windhover.com/windhover/content/conferences/passchedule09.asp
Topic Description
PharmAsia Summit is THE most strategic level meeting where senior level biotech and pharma executives share real-life case studies on how they are building a presence in Asia – from drug development to market. PharmAsia Summit will gather the industry’s most senior leaders to share best practice case studies, successful business models and strategic partnerships from discovery to clinical trials.
Join us for three days of interactive discussions, case studies and panels, and capitalize on Asia’s booming pharmaceutical market.
BEYOND THE BASICS! PharmAsia Summit is the only event featuring marquee level speakers and topics by the powerhouse editorial team from IN VIVO, START-UP, "THE PINK SHEET" and PHARMASIA NEWS. Discussions include:
* Heads of China R & D Roundtable: A Look at Different Models for Approaching Innovation in China
* China’s Changing Regulatory Landscape: The future of Chinese Healthcare Reform and What it Means for both Multinational and Chinese Companies
* Regulators Up Close: What can We Expect from Market Regulators in Asia?
* Indian Perspective on Globalization
* Partnering For Success In Emerging Markets: How Strategic Partnerships and M & A have Changed the Face of R & D in Asia
* Investment Outlook For Asia: VC Perspectives on their Best Bets
* Tips for Success: Working and Partnering with a CRO in Asia
* Building a Sales and Commercial Presence in China: How Do You Maximize Market Opportunities?
* Overcoming Intellectual Property Issues in Asia
* How to Conduct U.S. FDA Inspections in China
